MHRA Statement
Last updated: 23 April 2026
Statement regarding the Medicines and Healthcare products Regulatory Agency (MHRA)
Velox Peptides (operated by CRP Labs Ltd, Company No. NI738125) supplies research reagents for in vitro scientific research only.
No product sold by Velox Peptides is a medicinal product within the meaning of the Human Medicines Regulations 2012. No product sold by Velox Peptides has been evaluated by the MHRA. No product sold by Velox Peptides is licensed, registered, or authorised for human or veterinary medical use.
Velox Peptides makes no therapeutic, medical, or health claims regarding any product it supplies. All descriptive content on this website is derived from the peer-reviewed preclinical research literature and is provided for scientific reference only.
The sale of research reagents for in vitro scientific research is lawful in the United Kingdom. Products supplied for this purpose fall outside the regulatory scope of the Human Medicines Regulations 2012.
Any use of Velox Peptides products outside the scope of lawful in vitro scientific research is outside the scope of sale and is the sole responsibility of the end user.
For the avoidance of doubt:
- No Velox Peptides product is intended for human consumption.
- No Velox Peptides product is intended for veterinary use.
- No Velox Peptides product should be used to diagnose, treat, cure, mitigate, or prevent any disease.
- No Velox Peptides product is a food, food supplement, cosmetic, or consumer product.
If you have questions about the regulatory status of a specific product, contact veloxpeps@gmail.com.